LAG1 longevity assurance homolog 2 (LASS2) and Polypeptide N-acetylgalactosaminyltransferase 1 (GALNT1) were present in bladder cancer patients, whereas Rho guanine nucleotide exchange factor 39 (ARHGEF39) and Forkhead box protein O3 (FOXO3) were only found in controls. Here, ARHGEF39 is linked to urinary bladder carcinoma.